MET financials
MetLife, Inc. · end-of-day data as of Oct 16, 2026
MetLife, Inc.
$100.76+6.9%
Buy · 18 analystsPT $106.09 +5.3%
MET reported revenue of $18.88B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 9.9% from a year earlier. It posted diluted EPS of $1.08, free cash flow of $2.23B and a net margin of 3.9%.
Valuation
- P/E19.3x
- P/E vs own+24.3%
- P/E vs sector+35.9%
- FCF yield+25.9%
- Market cap$64.03B
Quarterly results
Q2 FY2026: Revenue +9.9% year over year, free cash flow 11.8% of revenue, operating margin 5.5%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $18.88B | 1.08 | $2.23B | 14.8% | 5.5% | 3.9% |
| Q1 FY2026 | Mar 31, 2026 | $19.07B | 1.74 | $2.69B | 37.2% | 7.9% | 6.2% |
| Q4 FY2025 | Dec 31, 2025 | $23.81B | 1.17 | $8.09B | 30.5% | 4.7% | 3.4% |
| Q3 FY2025 | Sep 30, 2025 | $16.88B | 1.22 | $3.57B | 17.4% | 7.2% | 5.3% |
| Q2 FY2025 | Jun 30, 2025 | $17.18B | 1.03 | $2.19B | 26.4% | 5.7% | 4.2% |
| Q1 FY2025 | Mar 31, 2025 | $18.26B | 1.28 | $4.26B | 25.9% | 7.4% | 5.2% |
| Q4 FY2024 | Dec 31, 2024 | $18.44B | 1.78 | $5.13B | 26.4% | 7.5% | 6.9% |
| Q3 FY2024 | Sep 30, 2024 | $18.3B | 1.81 | $4.17B | 29.8% | 10.9% | 7.3% |
| Q2 FY2024 | Jun 30, 2024 | $17.49B | 1.28 | $3.49B | 25.1% | 6.9% | 5.4% |
| Q1 FY2024 | Mar 31, 2024 | $15.9B | 1.10 | $2.33B | 28.2% | 6.6% | 5.5% |
| Q4 FY2023 | Dec 31, 2023 | $19.03B | 0.77 | $5.72B | 16.7% | 4.9% | 3.2% |
| Q3 FY2023 | Sep 30, 2023 | $15.87B | 0.56 | $3.48B | 16.8% | 3.4% | 3.1% |